BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen P, Fang QX, Chen DB, Chen HS. Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(7): 673-683 [PMID: 34322196 DOI: 10.4251/wjgo.v13.i7.673]
URL: https://www.wjgnet.com/1007-9327/full/v13/i7/673.htm
Number Citing Articles
1
Junze Liang, Yanxia Liao, Zhiwei Tu, Jinping Liu. Revamping Hepatocellular Carcinoma Immunotherapy: The Advent of Microbial Neoantigen VaccinesVaccines 2024; 12(8): 930 doi: 10.3390/vaccines12080930
2
Ben L. Da, Aiwu Ruth He, Kirti Shetty, Kelly I. Suchman, Herbert Yu, Lawrence Lau, Linda L. Wong, Atoosa Rabiee, Richard L. Amdur, James M. Crawford, Sharon S. Fox, Gregory M. Grimaldi, Priya K. Shah, Jonathan Weinstein, David Bernstein, Sanjaya K. Satapathy, Nyasha Chambwe, Xiyan Xiang, Lopa Mishra. Pathogenesis to management of hepatocellular carcinomaGenes & Cancer 2022; 13: 72 doi: 10.18632/genesandcancer.226
3
Pu Chen, Dongbo Chen, Dechao Bu, Jie Gao, Wanying Qin, Kangjian Deng, Liying Ren, Shaoping She, Wentao Xu, Yao Yang, Xingwang Xie, Weijia Liao, Hongsong Chen. Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigenJournal for ImmunoTherapy of Cancer 2023; 11(4): e006334 doi: 10.1136/jitc-2022-006334
4
Sumit Roy, Vancha Harish, Sharfuddin Mohd, Sachin Kumar Singh. Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma TreatmentAdvanced Therapeutics 2024;  doi: 10.1002/adtp.202400126
5
Jenni Viivi Linnea Niemi, Aleksandr V. Sokolov, Helgi B. Schiöth. Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial TreatmentsCancers 2022; 14(20): 5163 doi: 10.3390/cancers14205163
6
Amir Ghaffari Jolfayi, Zahra Taheri, Soroush Khojasteh-Kaffash, Seyedeh Zahra Hosseini Imani, Fatemeh Afra, Zohreh Tajabadi, Gita Manzari Tavakoli, Nima Rezaei. Handbook of Cancer and Immunology2024; : 1 doi: 10.1007/978-3-030-80962-1_404-1
7
Tzy Harn Chua, Lavisha S Punjabi, Li Yan Khor. Tissue Pathogens and Cancers: A Review of Commonly Seen Manifestations in Histo- and CytopathologyPathogens 2021; 10(11): 1410 doi: 10.3390/pathogens10111410
8
Yi-Fei Li, Qiong-Qiong Hou, Shuang Zhao, Xiaoyan Chen, Min Tang, Lin Li. Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine developmentJournal of Cancer Research and Clinical Oncology 2023; 149(2): 623 doi: 10.1007/s00432-022-04285-7
9
David Repáraz, Belén Aparicio, Diana Llopiz, Sandra Hervás-Stubbs, Pablo Sarobe. Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?International Journal of Molecular Sciences 2022; 23(4): 2022 doi: 10.3390/ijms23042022
10
Seokhwan Chung, Chan Mi Lee, Miqin Zhang. Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseasesNanoscale Horizons 2023; 8(1): 10 doi: 10.1039/D2NH00289B
11
M. V. Dmitrieva, M. A. Baryshnikovа, O. L. Orlova, V. S. Kosorukov. Technological aspects of creating neopeptide vaccinesRussian Journal of Biotherapy 2022; 21(4): 10 doi: 10.17650/1726-9784-2022-21-4-10-21
12
Nadine Soliman, Ashish Saharia, Maen Abdelrahim, Ashton A. Connor. Molecular profiling in the management of hepatocellular carcinomaCurrent Opinion in Organ Transplantation 2024; 29(1): 10 doi: 10.1097/MOT.0000000000001124
13
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, Niels Schaft, Jan Dörrie. Tumor Antigens beyond the Human ExomeInternational Journal of Molecular Sciences 2024; 25(9): 4673 doi: 10.3390/ijms25094673